Abstract
Abstract
Background
The COVID-19 pandemic brought attention to a need for rapid testing of large populations. Experiences from community-based testing settings show that there can be workload difficulties, logistical challenges and socioeconomic downsides to large scale Polymerase Chain Reaction (PCR) testing. Alternative testing arenas have therefore been considered. Rapid point-of-care (POC) PCR test methods have since been developed and could have potential to surveille viral respiratory infections. It is, however, unknown if PCR testing can be successfully implemented routinely in general practice. The aim of this study was to assess factors that enable and inhibit the implementation of point-of-care PCR testing for acute respiratory tract infection in general practice.
Methods
Fourteen general practices in the east Zealand area in Denmark were included in the study and given access to POC PCR testing equipment during a flu season. The participating clinics were initially trained in the use of a POC PCR testing device and then spent 6 weeks testing it. We conducted qualitative interviews with general practitioners (GPs) and their staff, before and after the testing period, specifically focusing on their clinical decision-making and internal collaboration in relation to POC PCR testing. We used normalization process theory to design the interview guides and to analyze the data.
Results
Professionals reported no clinical need for a POC PCR testing device in a non-pandemic clinical setting. Results were delivered faster, but this was only timesaving for the patient and not the GP, who had to perform more tasks.
Conclusion
In its current form, the added diagnostic value of using POC PCR testing in general practice was not sufficient for the professionals to justify the increased work connected to the usage of the diagnostic procedure in daily practice.
Trial registration
n/a.
Funder
University Library of Southern Denmark
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Kaye AD, Okeagu CN, Pham AD, Silva RA, Hurley JJ, Arron BL, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract Res Clin Anaesthesiol. 2021;35(3):293–306.
2. Gangula A, Kim B, Casey B, Hamill A, Regunath H, Upendran A. Point-of-Care Testing of COVID-19: Current Status, Clinical Impact, and Future Therapeutic Perspectives. In: Point-of-Care Testing of COVID-19 [Internet]. Singapore: Springer Nature Singapore; 2022 [cited 2022 Nov 15]. p. 1–70. (SpringerBriefs in Applied Sciences and Technology). Available from: https://link.springer.com/https://doi.org/10.1007/978-981-19-4957-9_1
3. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J [Internet]. 1995 Nov 15; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1487455/
4. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350(mar19 6):h1258–h1258.
5. Cooke J, Butler C, Hopstaken R, Dryden MS, McNulty C, Hurding S, et al. Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI). BMJ Open Respir Res. 2015;2(1):e000086.